NCT04678622

Brief Summary

Osteoarthritis of the hand is a chronic joint disease that usually affects one or more of the finger joints and it is a major cause of disability. Radiology and the Eaton-Littler classification (Stages I-II-III-IV) are used for its diagnosis. The treatment of stages I, II and in some cases of stage III, is based on pharmacological and rehabilitation measures, including the use of orthoses or splints. The development of Biosplint 3D will allow a qualitative leap forward in the search for an intelligent solution for patients with rhizarthrosis (Degenerative alteration of the trapezius-metacarpal joint (TMJ) characterized by a progressive deterioration of the articular surfaces and new bone formation in them). The aim of the study is to assess the feasibility of applying a personalized splint versus a conventional one. It is not a design aimed at evaluating the efficacy of such treatment. It is a prospective study with two arms, open with 1:1 allocation. The study includes a recruitment visit and two follow-up visits, one at a month and a final visit at 3 months. Patients with a new diagnosis of osteoarthritis of the trapeziometacarpal joint are included. One group of patients wears the usual splint indicated by the personalized doctors of the Service and the other group wears the 3D bi-splint. The main variable is pain, which will be measured by a visual analog scale (VAS). In addition, the DASH questionnaire (Disabilities of the Arm, Shoulder and Hand) and questions about patient satisfaction with the use of splints will be used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2018

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 27, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

December 16, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 22, 2020

Completed
Last Updated

December 28, 2020

Status Verified

December 1, 2020

Enrollment Period

1 month

First QC Date

December 16, 2020

Last Update Submit

December 23, 2020

Conditions

Keywords

Orthotic DevicesBiosplint 3DRhizarthrosisEaton-Littler I / II clasification3D technology

Outcome Measures

Primary Outcomes (1)

  • Pain measured: Change of pain in patients with clasic orthrosis compared to the orthrosis designed using 3D technology

    By visual analog scale from 0 (no pain) to 10 (unbereable pain)

    Pain measurement by visual analog scale is performed at the baseline visit, at the second visit (one month later) and at the third follow-up visit (end of the study) which will take place at the third month of follow-up (between 11-14 weeks).

Secondary Outcomes (2)

  • 3D orthoses change functionality

    Functionality is performed at the baseline visit, at the second visit (one month after) and at the third follow-up visit (end of the study), which will take place at the third month of follow-up (between 11-14 weeks).

  • Satisfaction and compliance are equally superior in the 3D orthosis.

    Satisfaction is performed at the second visit (one month after) and at the third follow-up visit (end of the study), which will take place at the third month of follow-up (between 11-14 weeks).

Other Outcomes (1)

  • There are no relevant differences between the two orthoses in terms of fist force and clamp force.

    It is performed at the second visit (one month after) and at the third follow-up visit (end of the study), which will take place at the third month of follow-up (between 11-14 weeks).

Study Arms (2)

Classic Orthrosis

Group of patients who they will wear the usual splint indicated by the servicio physicians

3D Orthrosis

Group of patients who they will wear the personalized splint designed by the company OPTIMUS 3D.

Device: Bioferula3D

Interventions

Custom splint with 3D technology classified as a custom medical device

3D Orthrosis

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with a new diagnosis of osteoarthritis of the trapeziometacarpal joint

You may qualify if:

  • Clinical diagnosis of osteoarthritis of the trapeziometacarpal joint.
  • Radiological stage of Eaton-Littler classification I / II.
  • Patients in whom the placement of a discharge splint is clinically indicated.
  • Score between 3 and 7 on the VAS pain scale (range 0 to 10).

You may not qualify if:

  • Previous treatment of osteoarthritis of the trapeziometacarpal joint.
  • Refuses to participate in the study.
  • Disabilities that prevent the completion of the questionnaires.
  • Presence of severe deformations in the hand.
  • Presence of other alterations, such as carpal tunnel syndrome, tendonitis or chronic inflammatory arthropathies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Optimus 3D S.L.

Vitoria-Gasteiz, Alava, 01510, Spain

Location

Hospital Universitario Basurto

Bilbao, Vizcaya, 48013, Spain

Location

Related Publications (9)

  • Cooper C, Egger P, Coggon D, Hart DJ, Masud T, Cicuttini F, Doyle DV, Spector TD. Generalized osteoarthritis in women: pattern of joint involvement and approaches to definition for epidemiological studies. J Rheumatol. 1996 Nov;23(11):1938-42.

    PMID: 8923371BACKGROUND
  • Gomes Carreira AC, Jones A, Natour J. Assessment of the effectiveness of a functional splint for osteoarthritis of the trapeziometacarpal joint on the dominant hand: a randomized controlled study. J Rehabil Med. 2010 May;42(5):469-74. doi: 10.2340/16501977-0542.

    PMID: 20544159BACKGROUND
  • Hirschfeld M, Galan A, Arenas J, Del Aguila B, Benitez-Parejo N, Costa JA, Guerado E. [Inter-observer agreement on the Eaton-Littler classification of trapeziometacarpal joint osteoarthritis]. Rev Esp Cir Ortop Traumatol. 2014 Jul-Aug;58(4):237-41. doi: 10.1016/j.recot.2014.01.006. Epub 2014 May 10. Spanish.

    PMID: 24821479BACKGROUND
  • Eaton RG, Littler JW. Ligament reconstruction for the painful thumb carpometacarpal joint. J Bone Joint Surg Am. 1973 Dec;55(8):1655-66. No abstract available.

    PMID: 4804988BACKGROUND
  • Spaans AJ, van Minnen LP, Kon M, Schuurman AH, Schreuders AR, Vermeulen GM. Conservative treatment of thumb base osteoarthritis: a systematic review. J Hand Surg Am. 2015 Jan;40(1):16-21.e1-6. doi: 10.1016/j.jhsa.2014.08.047.

    PMID: 25534834BACKGROUND
  • Barron OA, Glickel SZ, Eaton RG. Basal joint arthritis of the thumb. J Am Acad Orthop Surg. 2000 Sep-Oct;8(5):314-23. doi: 10.5435/00124635-200009000-00005.

    PMID: 11029559BACKGROUND
  • Bani MA, Arazpour M, Kashani RV, Mousavi ME, Maleki M, Hutchins SW. The effect of custom-made splints in patients with the first carpometacarpal joint osteoarthritis. Prosthet Orthot Int. 2013 Apr;37(2):139-44. doi: 10.1177/0309364612454047. Epub 2012 Aug 22.

    PMID: 22918521BACKGROUND
  • Hamann N, Heidemann J, Heinrich K, Wu H, Bleuel J, Gonska C, Bruggemann GP. Stabilization effectiveness and functionality of different thumb orthoses in female patients with first carpometacarpal joint osteoarthritis. Clin Biomech (Bristol). 2014 Dec;29(10):1170-6. doi: 10.1016/j.clinbiomech.2014.09.007. Epub 2014 Sep 19.

    PMID: 25266241BACKGROUND
  • Chiu NF, Huang TY, Kuo CC, Lin CW, Lee JH. Organic-based plasmonic emitters for sensing applications. Appl Opt. 2013 Mar 1;52(7):1383-8. doi: 10.1364/AO.52.001383.

    PMID: 23458789BACKGROUND

Study Officials

  • Iñigo Cearra Guezuraga, IP

    Biobizkaia Health Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2020

First Posted

December 22, 2020

Study Start

July 27, 2018

Primary Completion

August 27, 2018

Study Completion

December 31, 2018

Last Updated

December 28, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations